Literature DB >> 20742316

Unreviewed reports.

.   

Abstract

Year:  1984        PMID: 20742316      PMCID: PMC1442791     

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  6 in total

1.  Graves disease following congenital cytomegalovirus infection.

Authors:  S Salisbury; J A Embil
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

2.  Interferon in human serum after injection of endotoxin.

Authors:  C Sauter; C Wolfensberger
Journal:  Lancet       Date:  1980-10-18       Impact factor: 79.321

3.  Technical hazards of using nutritive mixtures in bags for cyclical intravenous nutrition: comparison with standard intravenous nutrition in 48 gastroenterological patients.

Authors:  B Messing; M Beliah; F Girard-Pipau; D Leleve; J J Bernier
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

4.  Determination of the glycosylated hemoglobins (HB AI) with a new microcolumn procedure. Suitability of the technique for assessing the clinical management of diabetes mellitus.

Authors:  E C Abraham; T A Huff; N D Cope; J B Wilson; E D Bransome; T H Huisman
Journal:  Diabetes       Date:  1978-09       Impact factor: 9.461

5.  A versatile new sustained-action neuroleptic: pipotiazine palmitate in psychiatric practice.

Authors:  R E Johnston; F Niesink
Journal:  J Int Med Res       Date:  1979       Impact factor: 1.671

6.  [Melanoma and dysplastic nevus after 8 years of topical Caryolysine].

Authors:  A Cosnes; J Revuz; J Wechsler; R Touraine
Journal:  Ann Dermatol Venereol       Date:  1984       Impact factor: 0.777

  6 in total
  2 in total

1.  Chemotypes of Mycobacterium malmoense based on glycolipid profiles.

Authors:  M L Katila; E Brander; E Jantzen; R Huttunen; L Linkosalo
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

2.  Melanocytic naevi and melanoma in survivors of childhood cancer.

Authors:  A Green; P Smith; W McWhirter; P O'Regan; D Battistutta; M E Yarker; K Lape
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.